BEAM financials
Beam Therapeutics (BEAM) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
BEAM income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $139.74M | $117.45M | -$383.69M | -$79.99M | -0.81 |
| 2024 | $63.52M | -$304.04M | -$415.57M | -$376.74M | -4.58 |
| 2023 | $377.71M | $377.71M | -$176.49M | -$132.53M | -1.72 |
| 2022 | $60.92M | -$250.67M | -$338.48M | -$289.09M | -4.13 |
| 2021 | $51.84M | -$180.29M | -$392.46M | -$370.64M | -5.77 |
| 2020 | $24.00K | -$103.16M | -$132.76M | -$194.59M | -5.49 |
- BEAM revenue was $139.74M in fiscal 2025, net income -$79.99M.
Updated 2026-11-03 02:01 UTC